DSIJ Mindshare

The share price of pharmaceutical major Sun Pharma plunged by over 7 per cent during the previous week on the back of declining sales of its key specialty products and speculation about price erosion.  

Every investor wants his investment to outperform. The mutual fund arena is well-known for steady returns in the longer term. But it too needs some diligence and planning to achieve maximum returns.

A new fund offer (NFO) is the first time offer for subscription from newly launched fund. The new fund offers are launched to raise the capital in respect to buy the shares or securities or bonds for the fund from the market. These offerings work similarly to IPOs. 

Suven Lifesciences reported strong result with good numbers across the board. The core manufacturing business witnessed robust growth aiding better top-line growth.

The loss after exceptional item for Q4FY18 came in at Rs. 783.54 crore as against a net profit of Rs. 380 crore in the corresponding quarter last year.